Leukemia Inhibitory Factor via the Toll-Like Receptor 5 Signaling Pathway Involves Aggravation of Cachexia Induced by Human Gastric Cancer-Derived 85As2 Cells in Rats

Oncotarget - United States
doi 10.18632/oncotarget.26190
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Toll-Like Receptor 7 Involves the Injury in Acute Kidney Ischemia/Reperfusion of STZ-induced Diabetic Rats

Acta Cirurgica Brasileira
Surgery
2016English

Hypoxia Exacerbates Inflammatory Acute Lung Injury via the Toll-Like Receptor 4 Signaling Pathway

Frontiers in Immunology
AllergyImmunology
2018English

Atorvastatin Suppresses LPS-induced Rapid Upregulation of Toll-Like Receptor 4 and Its Signaling Pathway in Endothelial Cells

American Journal of Physiology - Heart and Circulatory Physiology
Cardiovascular MedicinePhysiologyCardiology
2011English

Flotillin-1 Facilitates Toll-Like Receptor 3 Signaling in Human Endothelial Cells

Basic Research in Cardiology
Cardiovascular MedicinePhysiologyCardiology
2014English

Barrier Protection via Toll-Like Receptor 2 Signaling in Porcine Intestinal Epithelial Cells Damaged by Deoxynivalnol

Veterinary Research
Veterinary
2016English

Inflammatory Stimuli Promote Oxidative Stress in Pancreatic Acinar Cells via Toll-Like Receptor 4/Nuclear Factor-κB Pathway

International Journal of Molecular Medicine
MedicineGenetics
2018English

Loganetin Protects Against Rhabdomyolysis-Induced Acute Kidney Injury by Modulating the Toll-Like Receptor 4 Signaling Pathway

British Journal of Pharmacology
Pharmacology
2019English

Staurosporine Enhances ATRA-induced Granulocytic Differentiation in Human Leukemia U937 Cells via the MEK/ERK Signaling Pathway

Oncology Reports
MedicineCancer ResearchOncology
2016English

RRR-α-tocopheryl Succinate Induces Apoptosis in Human Gastric Cancer Cells via the NF-κB Signaling Pathway

Oncology Reports
MedicineCancer ResearchOncology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy